158 related articles for article (PubMed ID: 32209402)
1. APOE in Alzheimer's disease and neurodegeneration.
Butterfield DA; Johnson LA
Neurobiol Dis; 2020 Jun; 139():104847. PubMed ID: 32209402
[No Abstract] [Full Text] [Related]
2. MR spectroscopy, APOE genotype, and evolving β-amyloid pathology: What is being detected and when.
Kantarci K; Goldberg TE
Neurology; 2016 May; 86(19):1750-1. PubMed ID: 27164709
[No Abstract] [Full Text] [Related]
3. Apolipoprotein E4 and Alzheimer's disease pathology in Lewy body disease and in other beta-amyloid-forming diseases.
Pickering-Brown SM; Mann DM; Bourke JP; Roberts DA; Balderson D; Burns A; Byrne J; Owen F
Lancet; 1994 May; 343(8906):1155. PubMed ID: 7818636
[No Abstract] [Full Text] [Related]
4. APOE Genotype in the Era of Disease-Modifying Treatment With Monoclonal Antibodies Against Amyloid-β.
Ossenkoppele R; van der Flier WM
JAMA Neurol; 2023 Dec; 80(12):1269-1271. PubMed ID: 37930662
[No Abstract] [Full Text] [Related]
5. Apolipoprotein E, A beta-amyloid, and the molecular pathology of Alzheimer's disease. Therapeutic implications.
Kaplitt M; Gouras GK; Makimura H; Jovanovic J; Sweeney D; Greengard P; Relkin NR; Gandy S
Ann N Y Acad Sci; 1996 Dec; 802():42-9. PubMed ID: 8993483
[No Abstract] [Full Text] [Related]
6. Is there a relation between APOE expression and brain amyloid load in Alzheimer's disease?
Lambert JC; Mann D; Richard F; Tian J; Shi J; Thaker U; Merrot S; Harris J; Frigard B; Iwatsubo T; Lendon C; Amouyel P
J Neurol Neurosurg Psychiatry; 2005 Jul; 76(7):928-33. PubMed ID: 15965197
[TBL] [Abstract][Full Text] [Related]
7. The effect of apolipoprotein E genotype on biochemical markers of Alzheimer's disease.
Schenk D; Lieberburg I; Motter R; Seubert P
Ann N Y Acad Sci; 1996 Dec; 802():92-100. PubMed ID: 8993488
[No Abstract] [Full Text] [Related]
8. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
[TBL] [Abstract][Full Text] [Related]
9. Influence of Western diet and APOE genotype on Alzheimer's disease risk.
Sullivan PM
Neurobiol Dis; 2020 May; 138():104790. PubMed ID: 32032732
[No Abstract] [Full Text] [Related]
10. Preferential deposition of amyloid beta protein (Abeta) in the form Abeta40 in Alzheimer's disease is associated with a gene dosage effect of the apolipoprotein E E4 allele.
Mann DM; Iwatsubo T; Pickering-Brown SM; Owen F; Saido TC; Perry RH
Neurosci Lett; 1997 Jan; 221(2-3):81-4. PubMed ID: 9121705
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
12. APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein.
Chalmers K; Wilcock GK; Love S
Neuropathol Appl Neurobiol; 2003 Jun; 29(3):231-8. PubMed ID: 12787320
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E isoforms and the development of low and high Braak stages of Alzheimer's disease-related lesions.
Ohm TG; Scharnagl H; März W; Bohl J
Acta Neuropathol; 1999 Sep; 98(3):273-80. PubMed ID: 10483785
[TBL] [Abstract][Full Text] [Related]
14. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.
Corder EH; Saunders AM; Strittmatter WJ; Schmechel DE; Gaskell PC; Small GW; Roses AD; Haines JL; Pericak-Vance MA
Science; 1993 Aug; 261(5123):921-3. PubMed ID: 8346443
[TBL] [Abstract][Full Text] [Related]
15. Clinical and neuropathological correlates of apolipoprotein E genotype in Alzheimer's disease. Window on molecular epidemiology.
Hyman BT; Gomez-Isla T; West H; Briggs M; Chung H; Growdon JH; Rebeck GW
Ann N Y Acad Sci; 1996 Jan; 777():158-65. PubMed ID: 8624079
[TBL] [Abstract][Full Text] [Related]
16. Astrocytes down-regulate neuronal beta-amyloid precursor protein expression and modify its processing in an apolipoprotein E isoform-specific manner.
Vincent B; Smith JD
Eur J Neurosci; 2001 Jul; 14(2):256-66. PubMed ID: 11553277
[TBL] [Abstract][Full Text] [Related]
17. ApoE, amyloid, and Alzheimer's disease.
Hardy J
Science; 1994 Jan; 263(5146):454-5. PubMed ID: 8290946
[No Abstract] [Full Text] [Related]
18. There is a pathologic relationship between ApoE-epsilon 4 and Alzheimer's disease.
Corder EH; Saunders AM; Pericak-Vance MA; Roses AD
Arch Neurol; 1995 Jul; 52(7):650-1. PubMed ID: 7619017
[No Abstract] [Full Text] [Related]
19. A quartet of Down's syndrome, Alzheimer's disease, cerebral amyloid angiopathy, and cerebral haemorrhage: interacting genetic risk factors.
McCarron MO; Nicoll JA; Graham DI
J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):405-6. PubMed ID: 9728967
[No Abstract] [Full Text] [Related]
20. Association between apolipoprotein E e4 allele and arteriosclerosis, cerebral amyloid angiopathy, and cerebral white matter damage in Alzheimer's disease.
Tian J; Shi J; Bailey K; Lendon CL; Pickering-Brown SM; Mann DM
J Neurol Neurosurg Psychiatry; 2004 May; 75(5):696-9. PubMed ID: 15090562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
